Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Human ribonucleases (RNase) 3, 6 and 7, which belong to the ...

Class:IdSummation:8948025
_displayNameHuman ribonucleases (RNase) 3, 6 and 7, which belong to the ...
_timestamp2016-11-08 13:05:30
created[InstanceEdit:8948026] Shamovsky, Veronica, 2016-11-08
literatureReference[LiteratureReference:6803072] RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin
[LiteratureReference:6803083] Ribonucleases 6 and 7 have antimicrobial function in the human and murine urinary tract
[LiteratureReference:6803091] An endogenous ribonuclease inhibitor regulates the antimicrobial activity of ribonuclease 7 in the human urinary tract
[LiteratureReference:6803086] Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract
[LiteratureReference:6803058] Ribonuclease 7, an antimicrobial peptide upregulated during infection, contributes to microbial defense of the human urinary tract
[LiteratureReference:6803113] Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall
[LiteratureReference:6803080] RNase 7 contributes to the cutaneous defense against Enterococcus faecium
[LiteratureReference:6803136] RNase 7 protects healthy skin from Staphylococcus aureus colonization
[LiteratureReference:6803126] Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin
[LiteratureReference:6803133] Inflammatory and antimicrobial responses to methicillin-resistant Staphylococcus aureus in an in vitro wound infection model
[LiteratureReference:6803111] Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human beta-defensin 2
[LiteratureReference:6803020] The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity
[LiteratureReference:8866741] The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories
[LiteratureReference:8866739] LOC 390443 (RNase 9) on chromosome 14q11.2 is related to the RNase A superfamily and contains a unique amino-terminal preproteinlike sequence
[LiteratureReference:8866764] Identification of a member of a new RNase a family specifically secreted by epididymal caput epithelium
[LiteratureReference:8866757] The eight human "canonical" ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins
[LiteratureReference:8866729] Identification of RNase 8 as a novel human antimicrobial protein
[LiteratureReference:8866728] The antipathogen activities of eosinophil cationic protein
[LiteratureReference:8866763] Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7
[LiteratureReference:8866745] Human RNase 7: a new cationic ribonuclease of the RNase A superfamily
[LiteratureReference:8866758] Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity
[LiteratureReference:8866766] Structural determinants of the eosinophil cationic protein antimicrobial activity
[LiteratureReference:8947999] The expansion and functional diversification of the mammalian ribonuclease a superfamily epitomizes the efficiency of multigene families at generating biological novelty
[LiteratureReference:8948008] The ribonuclease A superfamily: general discussion
[LiteratureReference:8948007] RNase A ribonucleases and host defense: an evolving story
[LiteratureReference:8948011] Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence
[LiteratureReference:8948009] Eosinophil-Derived Neurotoxin (EDN/RNase 2) and the Mouse Eosinophil-Associated RNases (mEars): Expanding Roles in Promoting Host Defense
[LiteratureReference:8948000] The success of the RNase scaffold in the advance of biosciences and in evolution
[LiteratureReference:8947985] Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation
[LiteratureReference:8948003] The first crystal structure of human RNase 6 reveals a novel substrate-binding and cleavage site arrangement
[LiteratureReference:8948012] Structural basis for endotoxin neutralization by the eosinophil cationic protein
[LiteratureReference:8948001] Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure
[LiteratureReference:8947991] A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities
[LiteratureReference:8948006] Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus
[LiteratureReference:8948002] Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation
textHuman ribonucleases (RNase) 3, 6 and 7, which belong to the RNase A superfamily and are secreted upon infection, interact with the bacterial cell membrane (Torrent M et al. 2010; Pulido D et al. 2016a, b).

RNase A family is a vertebrate-specific gene family (Goo SM & Cho S 2013). Members of RNase A family share specific elements of sequence homology, a unique disulfide-bonded tertiary structure, and the ability to hydrolyze polymeric RNA (Beintema JJ & Kleineidam RG 1998; Rosenberg HF 2008). Eight catalytically active members are found in humans: RNase1 (pancreatic RNase), RNase2 (eosinophil derived neurotoxin/EDN), RNase3 (eosinophil cationic protein/ECP), RNase4, RNase5 (angiogenin), RNase6, RNase7 (skin-derived RNase), and RNase8 (divergent paralog of RNase7) (Sorrentino S 2010). Analysis of human genome sequence has revealed the existence of five additional RNases named as RNases 9-13, although they appear to lose enzymatic activity (Devor EJ et al. 2004; Castella S et al. 2004; Cho S et al. 2005). All human RNase A family members encode relatively small polypeptides of 14 to 16kDa containing signal peptides of 20 to 28 amino acids for protein secretion. Mature RNases contain 6 to 8 cysteine residues that are crucial to hold the overall tertiary structure (Sorrentino S 2010). Apart from the ribonuclease activity the RNase A family members have been implicated in a wide variety of biological actions including antipathogen and immunomodulatory activities (Harder J & Schroder JM 2002; Rudolph B et al. 2006; Boix E et al. 2008; Boix and Nogués, 2007; Spencer JD et al. 2011; Becknell B et al. 2015; Rosenberg HF 2015). Evidence of antimicrobial properties displayed by distantly related members ascribed to the family an ancestral role in host defence (Pizzo E & D’Alessio G 2007; Rosenberg HF et al. 2008).

RNase3, RNase6 and RNase7 have been identified as the most potent human antibacterial ribonucleases with a broad antimicrobial action against Gram-positive and Gram-negative bacteria (Pulido D et al. 2013, 2016; Zhang J et al. 2003; Boix E et al. 2008; Torrent M et al. 2010). Mutagenesis analysis revealed that ribonuclease-inactive RNase7 protein exhibited similar anti-microbial activity against P. aeruginosa, E. faecium and E. coli as the wild-type protein suggesting that RNase7 may kill bacteria independently of its ribonuclease catalytic activity (Huang YC et al. 2007; Koten B et al. 2009). Similar results were reported on microbicidal effect of ribonuclease-inactive RNase3 and 6 proteins against S. aureus (Rosenberg HF 1995; Pulido D et al. 2016a). Being cationic proteins with a high pI, RNase3, 6 and 7 interact with anionic components of biological membranes (Zhang J et al. 2003; Boix E et al. 2008; Torrent M et al. 2010; Boix E et al. 2012; Pulido D et al. 2016a). RNase3, 6 and 7 present, respectively, a high number of either Arg, His or Lys surface-exposed residues that may contribute to their distinct bactericidal mechanisms of action (Torrent M et al. 2010; Prats-Ejarque G et al. 2016). RNase3 displays a membrane disruption capacity that is dependent on both surface exposed hydrophobic and cationic residues. RNase3 can bind and partially insert into the lipid bilayers, promoting its aggregation and final lysis, following a carpet-like mechanism. The RNase3 agglutination process precedes the bacterial death and lysis event. The antimicrobial properties of the RNase6 are comparable to its RNase3 homolog and correlate to the bacterial cell damage and agglutination activities (Pulido D et al. 2016a). In contrast, RNase7 has no significant membrane aggregation capacity (Torrent M et al. 2010). RNase7 binds and permeabilizes the bacterial membrane displaying a much higher leakage capacity compared to RNase3 (Torrent M et al. 2010; Huang YC et al. 2007). Membrane permeabilization by RNase7 required four clustered lysine residues but no catalytic residues (Huang YC et al. 2007). Binding to PGN and LPS has been reported for RNases 3 and 7 (Torrent M et al. 2010; Pulido D et al. 2016b). Studies using a battery of progressively truncated LPS-defective E. coli strains correlated the LPS interaction with the protein cell agglutination and bactericidal activities (Pulido D et al. 2012). Further work indicated that RNase3 and RNase 6 high cell agglutination activity towards Gram negative species is retained by their respective N-terminus peptides (Torrent M et al. 2012, 2013; Pulido D et al. 2016c). In particular, the RNase3 N-terminus encompasses a specific patch (Y33-R36) required for LPS binding and an hydrophobic aggregation prone region (A8-I16) that mediates the protein self amyloid- like aggregation and promotes the cell death.

(summation)[Reaction:8948027] RNASEs bind bacterial phospholipids [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Human ribonucleases (RNase) 3, 6 and 7, which belong to the ... (8948025)